Inventor
Philip J. Pye
Inventor
Guttenberg, NJ, US
Overview
Patents· 24 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds43%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations18%
A61KPreparations for medical, dental or toiletry purposes11%
C07CAcyclic or carbocyclic compounds11%
C07BGeneral methods of organic chemistry7%
B01JChemical or physical processes, e.g. catalysis or colloid chemistry5%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium4%
Y02PClimate change mitigation technologies in the production or processing of goods2%
PatentTitleYear
10,464,939Deuterated triazolopyridazine as a kinase modulator201910,138,246Deuterated triazolopyridazine as a kinase modulator20189,156,847'Processes and intermediates for preparing a medicament'20159,079,900'Methods of synthesis and purification of heteroaryl compounds'20158,686,135'Methods of synthesis and purification of heteroaryl compounds'20148,569,494'Methods of synthesis and purification of heteroaryl compounds'20138,357,798'Process for preparing N-alkylated hydroxypyrimidinone compounds'20137,598,264'HIV integrase inhibitors'20096,914,144'Process for preparing integrin antagonist intermediate'20056,538,134'4-Benzyl-2-hydroxy-1,4-oxazine-3-one and polymorphic forms thereof'20036,469,164'Process for the synthesis of (2R, 2-alpha-R)-4-benzyl-2-1-(3,5-bis (trifluoromethyl)phenyl)ethoxy-1,4-oxazine-3-one'20026,403,793'Intramolecular glycosidation process for the synthesis of (2R, 2-alpha-R, 3a)-2-1-(3,5- bis (trifluoromethyl) phenyl)ethoxy-3-(4-fluorophenyl)-1,4-oxazine'20026,395,894'Process for the synthesis of carbapenem intermidiates, and compounds produced'20026,369,275'Process for making diaryl pyridines useful as cox-2 inhibitors'20026,252,116'Intermediates useful in a process for synthesizing COX-2 inhibitors'20016,204,387'Process for making diaryl pyridines useful as COX-2 inhibitors'20016,156,895'Process for preparing 4-tert-butyloxycarbonyl-(S)-piperazine-2-tert-butylcarboxamide'20006,130,334'Process for making 2-aryl-3-aryl-5-halo pyridines useful as COX-2 inhibitors'20006,127,545'Process for making 2-aryl-3-aryl-5-halo pyridines useful as COX-2 inhibitors'20006,043,387'Chiral bisphosphines'20006,040,450'Process for making diaryl pyridines useful as cox-2-inhibitors'20006,040,319'Process for synthesizing COX-2 inhibitors'20005,977,364'Process for preparing 4-tert-butyloxycarbonyl-(S)-piperazine-2-tert-butylcarboxamide'19995,874,629'Chiral bisphosphines'1999Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1999–2009Patents assigned to MERCK & CO INC (16)· patent assignee history
1999–2013Based in Guttenberg, NJ, US· patent location history
2002Based in Rahway, NJ, US· patent location history
2013–2015Patents assigned to SIGNAL PHARM LLC (3)· patent assignee history
2013Patents assigned to ANGELAUD REMY (1)· patent assignee history
2013Patents assigned to BEAUCHAMPS MARIE GEORGES (1)· patent assignee history
2013–2015Based in Kasterlee, BE· patent location history
2015–2019Patents assigned to JANSSEN PHARMACEUTICA NV (3)· patent assignee history
2015–2019Based in Beerse, BE· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| MERCK & CO INC | 16 | 1999–2009 |
| JANSSEN PHARMACEUTICA NV | 3 | 2015–2019 |
| SIGNAL PHARM LLC | 3 | 2013–2015 |
| ANGELAUD REMY | 1 | 2013 |
| BEAUCHAMPS MARIE GEORGES | 1 | 2013 |
Locations
| Location | Patents | Span |
|---|---|---|
| Guttenberg, New Jersey, US | 17 | 1999–2013 |
| Beerse, BE | 3 | 2015–2019 |
| Kasterlee, BE | 3 | 2013–2015 |
| Rahway, New Jersey, US | 1 | 2002 |